P3 Health Partners Inc. (PIIIW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -81.07 Million USD | 47.89% |
| 2022 | -1.46 Billion USD | 99.5% |
| 2021 | -184.61 Million USD | -91410.91% |
| 2020 | -28.08 Million USD | 12.07% |
| 2019 | -39.03 Million USD | 20.93% |
| 2018 | -49.37 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -22.29 Million USD | 47.82% |
| 2024 Q2 | -9.64 Million USD | 96.89% |
| 2023 FY | - USD | 47.89% |
| 2023 Q2 | 6000.00 USD | 100.02% |
| 2023 Q4 | -42.62 Million USD | -257.93% |
| 2023 Q3 | -11.9 Million USD | -198583.33% |
| 2023 Q1 | -27.18 Million USD | 43.72% |
| 2022 FY | - USD | 99.5% |
| 2022 Q4 | -48.3 Million USD | -26.45% |
| 2022 Q3 | -38.19 Million USD | 2.09% |
| 2022 Q2 | -39.01 Million USD | -28.26% |
| 2022 Q1 | -30.41 Million USD | 99.91% |
| 2021 Q1 | -12.65 Million USD | -208.77% |
| 2021 FY | - USD | -91410.91% |
| 2021 Q4 | -33.85 Billion USD | -128776.61% |
| 2021 Q3 | -26.26 Million USD | -46.86% |
| 2021 Q2 | -17.88 Million USD | -41.32% |
| 2020 Q4 | -4.09 Million USD | 69.11% |
| 2020 Q2 | -4.47 Million USD | 24.82% |
| 2020 Q1 | -5.95 Million USD | 0.0% |
| 2020 Q3 | -13.26 Million USD | -196.59% |
| 2020 FY | - USD | 12.07% |
| 2019 FY | - USD | 20.93% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 142.869% |
| Addus HomeCare Corporation | 106.55 Million USD | 176.082% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 386.349% |
| Amedisys, Inc. | 216.91 Million USD | 137.375% |
| American Oncology Network, Inc. | -39.35 Million USD | -106.02% |
| Astrana Health, Inc. | 123.68 Million USD | 165.545% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 282.806% |
| IMAC Holdings, Inc. | -5.94 Million USD | -1263.272% |
| biote Corp. | 9.23 Million USD | 977.962% |
| Cryo-Cell International, Inc. | -10.41 Million USD | -678.235% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 162.683% |
| COMPASS Pathways plc | -123.8 Million USD | 34.516% |
| DocGo Inc. | 32.72 Million USD | 347.733% |
| The Ensign Group, Inc. | 353.23 Million USD | 122.951% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 207.79% |
| InnovAge Holding Corp. | 1.15 Million USD | 7125.217% |
| Assure Holdings Corp. | -19.82 Million USD | -308.954% |
| The Joint Corp. | 9.14 Million USD | 986.824% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 22.735% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | -421.2% |
| ModivCare Inc. | -26.75 Million USD | -203.069% |
| NewGenIvf Group Limited | 384.3 Thousand USD | 21195.484% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | -1286.066% |
| Option Care Health, Inc. | 376.79 Million USD | 121.516% |
| P3 Health Partners Inc. | -81.07 Million USD | -0.0% |
| The Pennant Group, Inc. | 30.36 Million USD | 366.953% |
| Surgery Partners, Inc. | 446.1 Million USD | 118.173% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | -2758.754% |
| Talkspace, Inc. | -22.01 Million USD | -268.287% |
| Talkspace, Inc. | -22.01 Million USD | -268.287% |
| The Oncology Institute, Inc. | -70.45 Million USD | -15.069% |
| The Oncology Institute, Inc. | -70.45 Million USD | -15.069% |